B. Metzler seel. Sohn & Co’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $965K | Hold |
9,241
| – | – | 0.01% | 551 |
|
|
2025
Q1 | $1.08M | Hold |
9,241
| – | – | 0.01% | 504 |
|
|
2024
Q4 | $782K | Hold |
9,241
| – | – | 0.01% | 578 |
|
|
2024
Q3 | $830K | Hold |
9,241
| – | – | 0.01% | 576 |
|
|
2024
Q2 | $744K | Hold |
9,241
| – | – | 0.01% | 577 |
|
|
2024
Q1 | $737K | Hold |
9,241
| – | – | 0.01% | 569 |
|
|
2023
Q4 | $735K | Buy |
9,241
+1,056
| +13% | +$84K | 0.01% | 551 |
|
|
2023
Q3 | $572K | Sell |
8,185
-6,975
| -46% | -$487K | 0.01% | 563 |
|
|
2023
Q2 | $1.09M | Buy |
15,160
+8,059
| +113% | +$579K | 0.01% | 477 |
|
|
2023
Q1 | $438K | Buy |
7,101
+660
| +10% | +$40.7K | 0.01% | 572 |
|
|
2022
Q4 | $497K | Sell |
6,441
-3,869
| -38% | -$298K | 0.01% | 557 |
|
|
2022
Q3 | $460K | Buy |
10,310
+556
| +6% | +$24.8K | 0.01% | 554 |
|
|
2022
Q2 | $374K | Hold |
9,754
| – | – | 0.01% | 607 |
|
|
2022
Q1 | $404K | Buy |
+9,754
| New | +$404K | 0.01% | 640 |
|